News

CIT GAP Funds Portfolio Company, TypeZero Technologies, Acquired by Dexcom

CIT is proud to announce that its CIT GAP Funds portfolio company, TypeZero Technologies, Inc. was acquired by Dexcom, Inc., the leader in continuous glucose...

CIT GAP Funds Invests in Embody

CIT announced today that CIT GAP Funds has invested in Embody, a Norfolk, Virginia based medical device company developing collagen-based products for...

CIT Investment Director, Jennifer O’Daniel, to Present Black Hat Innovation Session

The Center for Innovative Technology (CIT) today announced that Investment Director Jennifer O’Daniel has been selected to present a panel at Black Hat...